With Momentum
mybacs
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
mybacs is a research-driven DTC company specialized in the human microbiome.
HQ Location
Switzerland
Founded
2019
Employees
11 - 50
Total funding raised
$7.67M
Last Funding Event
Series A, $5.93M, October 19, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Operator of a synbiotic dietary supplements company intended to serve the healthcare market. The company's supplements are for the human microbiome, personalized and adapted to the different needs of the customers while being gluten-free, lactose-free and free of any chemical side effects, enabling customers to improve digestion and prevent diarrhea.